Clinical trial NCT06687746 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-03-03 3. primary completion date: 2026-04-01 → 2026-03-03 4. enrollment: not set → 4060 participants
Clinical trial NCT07290283: enrollment: not set → 176 participants.
The company’s outstanding liabilities as of March 31, 2026, by maturity dates
Clinical trial NCT06455449: enrollment: not set → 240 participants.
Clinical trial NCT07607743: enrollment: not set → 240 participants.
Clinical trial NCT06880744 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2028-09-01 → 2027-08-01 3. enrollment: not set → 573 participants
Clinical trial NCT07205081 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 72 participants
Clinical trial NCT06136559: enrollment: not set → 1200 participants.
Clinical trial NCT06971809 updates: 1. start date: 2024-10-01 → 2025-05-31 2. completion date: 2025-10-31 → 2026-03-31 3. primary completion date: 2025-10-01 → 2025-12-31 4. enrollment: not set → 60 participants
Clinical trial NCT06901531: enrollment: not set → 500 participants.